United States · FDA National Drug Code directory
Lidocaine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-591_9312d01c-00d0-4e8b-b6b6-3aaf80e25d8a
- Product NDC
- 59651-591
- Form
- OINTMENT
- Composition / generic term
- Lidocaine
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240618
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE — 50 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (59651-591-30) / 30 g in 1 TUBE · 59651-591-30
- 1 TUBE in 1 CARTON (59651-591-35) / 35.44 g in 1 TUBE · 59651-591-35
- 50 g in 1 JAR (59651-591-50) · 59651-591-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →